Azitra Inc. AZTR 深 沪
已收盘 10-31 16:00:00 美东时间
0.523
-0.067
-11.36%
华盛通- 最 高0.5591
- 今 开0.5332
- 成交量 349.07万股
- 最 低 0.4963
- 昨 收 0.59
- 总市值 282.68万
- 52周最高 4.329
- 市盈率 静 --
- 换手率 64.58%
- 52周最低 0.4668
- 委 比 0.00%
- 总股本 540.50万
- 历史最高 1034.964
- 量 比 0.50
- 振 幅 10.64%
- 历史最低 0.4963
- 每 手 1
- 风险率 0.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Azitra To Present Preclinical Progress For ATR-01 Program, Targeting Treatment Of Ichthyosis Vulgaris At BIO-Europe Conference
ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgarisPreclinical data show production of active, functional filaggrin delivered through human stratum
10-20 20:10
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
Azitra Inc Faces NYSE Compliance Deadline Notice
Azitra Inc ( ($AZTR) ) has provided an update. On October 1, 2025, Azitra, Inc....
10-04 05:17
Azitra Receives Notice of Non-Compliance from NYSE American
BRANFORD, Conn., Oct. 3, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatol...
10-04 04:45
Azitra Stock (AZTR) Rockets on Clinical Trial Update
Azitra stock rallied on Wednesday alongside a clinical trial update.
08-27 21:25
Why Azitra Stock Shot Up 59% After-Hours?
Azitra shares surged over 58% after hours following a reverse stock split and new institutional ownership disclosure by Alumni Capital.
08-22 12:25
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers FibroGen (NASDAQ:FGEN) shares rose 20.1% to $10.11 during Monday's aft...
08-12 05:06
Azitra shares are trading lower after the company announced a 1-for-6.66 reverse stock split.
Azitra shares are trading lower after the company announced a 1-for-6.66 revers...
08-12 04:38
Azitra, Inc. Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on August 21, 2025 BRANFORD, Conn., Aug. 11, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceut...
08-12 04:15
